These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35223105)

  • 21. Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary.
    Spatafora S; Conti G; Perachino M; Casarico A; Mazzi G; Pappagallo GL;
    Curr Med Res Opin; 2007 Jul; 23(7):1715-32. PubMed ID: 17588302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal allergies in the Middle Eastern population: Results from the "Allergies in Middle East Survey".
    Abdulrahman H; Hadi U; Tarraf H; Gharagozlou M; Kamel M; Soliman A; Hamad WA; Hanna KM; Mostafa BE; Omrani M; Abdelmotal A; Moukarzel N
    Am J Rhinol Allergy; 2012 Nov; 26(6):3-23. PubMed ID: 29025459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey.
    Foster SA; Annunziata K; Shortridge EF; Freedman D; Viktrup L
    Curr Med Res Opin; 2013 Dec; 29(12):1709-17. PubMed ID: 23971532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy.
    Apolone G; Cattaneo A; Colombo P; La Vecchia C; Cavazzuti L; Bamfi F
    Eur J Cancer Prev; 2002 Oct; 11(5):473-9. PubMed ID: 12394245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Hakimi Z; Herdman M; Pavesi M; Devlin N; Nazir J; Hoyle C; Odeyemi IA
    Qual Life Res; 2017 May; 26(5):1187-1195. PubMed ID: 27896711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients].
    Costa P; Ben Naoum K; Boukaram M; Wagner L; Louis JF
    Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
    Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign Prostatic Hyperplasia and the Risk of Falls in Older Men: Insights From a Population-Based Study on Geriatric Morbid Conditions.
    Kim SJ; Lee D; Park SG; Pak S; Lee YG; Cho ST
    Int Neurourol J; 2024 Mar; 28(1):44-51. PubMed ID: 38569619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older.
    Safarinejad MR
    Int Urol Nephrol; 2008; 40(4):921-31. PubMed ID: 18246438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
    Shakya G; Malla S; Shakya KN
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].
    Kim HH; Kong KA; Lee HJ; Yoon H; Lee BE; Moon OR; Park H
    J Prev Med Public Health; 2006 Mar; 39(2):141-8. PubMed ID: 16615269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].
    Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A
    Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia.
    Schulz MW; Chen J; Woo HH; Keech M; Watson ME; Davey PJ
    J Urol; 2002 Jul; 168(1):155-9. PubMed ID: 12050512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical activity and benign prostatic hyperplasia.
    Platz EA; Kawachi I; Rimm EB; Colditz GA; Stampfer MJ; Willett WC; Giovannucci E
    Arch Intern Med; 1998 Nov; 158(21):2349-56. PubMed ID: 9827786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
    Verhamme KM; Dieleman JP; Bleumink GS; van der Lei J; Sturkenboom MC; Artibani W; Begaud B; Berges R; Borkowski A; Chappel CR; Costello A; Dobronski P; Farmer RD; Jiménez Cruz F; Jonas U; MacRae K; Pientka L; Rutten FF; van Schayck CP; Speakman MJ; Sturkenboom MC; Tiellac P; Tubaro A; Vallencien G; Vela Navarrete R;
    Eur Urol; 2002 Oct; 42(4):323-8. PubMed ID: 12361895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.